Otros idiomas PT Kalbe Farma Tbk.

Acciones

KLBF

ID1000125107

Precio de cierre INDONESIA S.E. Otros sitios de cotización 00:00:00 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
1.490 ^IDR	0,00 %		+6,05 %	-7,45 %

30/04	PT Kalbe Farma Tbk. Resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
01/04	PT Kalbe Farma Tbk. Resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

PT Kalbe Farma Tbk : Company Update - Q1 2024 Unaudited Results (02-May-2024)	02/05
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2023	31/10/23
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)	23/10/23
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius novel anti-PD-1 mAb HANSIZHUANG in MENA	13/09/23
PT Kalbe Farma Tbk : KIMIA FARMA & KALBE FARMA COLLABORATED TO IMPROVE HEALTH SERVICES FOR THE SOCIETY	01/09/23
PT Kalbe Farma Tbk. Reports Earnings Results for the Half Year Ended June 30, 2023	07/08/23
PT Kalbe Farma Tbk : KALBE INTRODUCES MESOTHERAPY PRODUCTS IN AESTHETIC TREATMENT	17/07/23
PT Kalbe Farma Tbk : KALBE INTRODUCES AUTOIMMUNE DISEASES FURTHER	08/07/23
PT Kalbe Farma Tbk : Kalbe Announced Dividend of 52% from Net Profit	04/05/23
PT Kalbe Farma Tbk : 2022, Recover Together for Healthier Nation	02/05/23
PT Kalbe Farma Tbk : Kalbe Maintained Double Digit Top Line Growth in the First Quarter of 2023	28/04/23
PT Kalbe Farma Tbk : Company Update - Q1 2023 Unaudited Results (28-April-2023)	28/04/23
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2022	28/03/23
PT Kalbe Farma Tbk : THE INAUGURATION OF THE KALBE UBAYA HANBANG-BIO LABORATORY PILOT PLANT, SUPPORTING THE INDEPENDENCE OF NATIONAL INGREDIENTS	02/03/23
Progen Co. Ltd. announced that it has received IDR 155.72 billion in funding from PT Kalbe Farma Tbk.	02/01/23
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2022	31/10/22
PT Kalbe Farma Tbk. completed the acquisition of a 80% stake in PT Aventis Pharma from Hoechst GmbH and Sanofi-Aventis Participations S.A.S.	26/10/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas PT Kalbe Farma Tbk.

Acciones

KLBF

ID1000125107

Otros idiomas

Filtros